Abaloparatide Reference

Plain English

What it is

Abaloparatide, sold under the brand name Tymlos, is an FDA-approved prescription medicine for osteoporosis (weak, fragile bones). It is a lab-made copy of part of a natural body hormone that signals the body to grow new bone.

What people use it for

It is prescribed to build up bone and lower the chance of breaks in women past menopause and in men who have osteoporosis with a high risk of fractures.

What the science shows

It is backed by human studies in its FDA label, where it raised bone density and reduced fractures. It is in the same bone-building class as teriparatide (Forteo).

The catch

This is a prescription-only medicine, not a research peptide. The label warns that blood pressure can drop soon after use and cause dizziness, and it is not recommended for people with high blood calcium. The label also notes lifetime use of this bone-building class is limited and is not recommended beyond a set time.

Reference summary

Abaloparatide is a label-verified PTHrP analog with approved-label osteoporosis evidence. pepSmart surfaces label-reference content only and is not a prescribing tool.

Regulatory and posture

Categories

Bone, Hormonal

Aliases

Tymlos, PTHrP analog

Evidence posture

human

Regulatory status

FDA-approved prescription medication (Tymlos). Labeled for osteoporosis treatment in postmenopausal women and in men at high risk of fracture. Cumulative lifetime exposure (teriparatide plus abaloparatide) should not exceed 2 years per label.

Content review status

label verified

Related tools

• Injection-site rotation overview - Public overview of the Pro site-rotation planner.